The Journal of Inflammation (JMI), (Parthasarathy, G; et al.) published “The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions,” January 17, 2023. In […]
Search Results for: treatment
Jay Holmgren, Ph.D., MHI, et al, published “Association Between Billing Patient Portal Messages as e-Visits and Patient Messaging Volume” online, in JAMA, on January 6, 2023. The purpose of the study was to analyze the utilization of clinician-initiated e-visit billing which expanded following the onset of the COVID-19 pandemic. The researchers sought to better understand the level at which clinicians adopted the revised billing protocols as they related to patient messaging behavior.
Columbia University Irving Medical Center’s Clinical Trials Network (CTN) for Lyme and Other Tick-Borne Diseases, established with a grant from the Steven & Alexandra Cohen Foundation to Columbia University, has announced the third round of Pilot Study Proposal submissions. Clinicians, researchers, and investigators from educational institutions are welcome to submit proposals.
PA Lyme Resources Presents Lyme Impact Series – LDA President, Pat Smith on Lyme Disease: 47 years – Past, Present & Moving Forward, May 17th, 2022 TOPICS COVERED IN VIDEO: […]
Katherine Leavey, et al., published, “Lyme borreliosis in pregnancy and associations with parent and offspring health outcomes: An international cross-sectional survey” in Frontiers in Medicine on November 3, 2022. Data regarding the health outcomes of people infected with Lyme disease during pregnancy is limited, as is perinatal transmission to their fetus, and the long-term effects on their children…
Timothy C. Saylor, et al., published “Borrelia burgdorferi, the Lyme disease spirochete, possesses genetically-encoded responses to doxycycline, but not to amoxicillin” in PLOS ONE on September 30, 2022. The study examines whether B. burgdorferi responds to antibiotic stresses by creating proteins that provide a safeguard against antibiotics, and therefore changing its transcription profile, as some species of bacteria have been found to do.
The U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation (Cohen Foundation) have named ten Phase 1 LymeX Diagnostics Prize winners in the LymeX Innovation Accelerator (LymeX) contest created to advance the progress of diagnostics for Lyme disease. Phase 1 of the multiphase competition called on scientific, technical, and clinical experts to present pioneering methodologies for the detection of active Lyme disease infections in humans with the goal of cultivating the advancement of diagnostics toward review by the Food and Drug Administration.
Shannon Baron, et al., published, “Unresolved Heart Block in Lyme Carditis: A Case Report” in Cureus on September 27, 2022, chronicling the case of a man who was admitted to the emergency department with a day-long history of syncopal episodes.
When the Lyme Disease Association Inc. (LDA) was contacted by a student at Duke Law who wanted to organize a group of students in a Lyme disease pro bono project, I was very excited about the possibilities…Lyme is not just a disease but a political nightmare… this was an opportunity to have some of the brightest and most motivated of our youth tackle this epidemic….The findings from this group of law students can be disseminated and used to empower patients, families, physicians, politicians, and researchers to unravel the secrets surrounding Lyme and provide solutions for Lyme and other tick-borne diseases across the globe.
LDA Guest Bloggers – Luke Mears & Madison Pinckney are second-year law students at Duke University School of Law. We formed the Lyme Disease Advocacy Project in February of 2022 after our experiences contracting and combating Lyme disease. Our hope for the project was multifaceted. We sought to provide legal research and writing for the Lyme Disease Association, Inc. (LDA) hoping to answer legal questions as they lobbied for increased resources and better treatment for Lyme disease.